These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20228601)

  • 1. Familial Hodgkin's lymphoma from the perspective of HLA.
    Sonmez M; Erkut N; Ucar F; Buruk K; Cobanoglu U; Bahce M; Ural AU
    Intern Med; 2010; 49(6):607-10. PubMed ID: 20228601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
    Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigens and genetic susceptibility to lymphoma.
    McAulay KA; Jarrett RF
    Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Hodgkin's disease and associated cancer. A clinical-pathologic study.
    Lynch HT; Saldivar VA; Guirgis HA; Terasaki PI; Bardawil WA; Harris RE; Lynch JF; Thomas R
    Cancer; 1976 Nov; 38(5):2033-41. PubMed ID: 991117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.
    Niens M; van den Berg A; Diepstra A; Nolte IM; van der Steege G; Gallagher A; Taylor GM; Jarrett RF; Poppema S; te Meerman GJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2280-4. PubMed ID: 17119058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.
    Fletcher LB; Veenstra RN; Loo EY; Hwang AE; Siddiqi IN; Visser L; Hepkema BG; Nolte IM; van den Berg A; Cozen W; Diepstra A
    PLoS One; 2017; 12(3):e0174457. PubMed ID: 28334025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA associations in classical Hodgkin lymphoma: EBV status matters.
    Huang X; Kushekhar K; Nolte I; Kooistra W; Visser L; Bouwman I; Kouprie N; Veenstra R; van Imhoff G; Olver B; Houlston RS; Poppema S; Diepstra A; Hepkema B; van den Berg A
    PLoS One; 2012; 7(7):e39986. PubMed ID: 22808081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations of HLA-A, -B, DRB1 alleles and haplotypes in Turkish lymphoma patients.
    Uçar F; Sönmez M; Ermantaş N; Özbaş HM; Cansız A; Balcı M; Yılmazz M
    Gene; 2016 Jul; 586(2):263-7. PubMed ID: 27063556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Hodgkin's disease. A clinical and laboratory investigation.
    Robertson SJ; Lowman JT; Grufferman S; Kostyu D; van der Horst CM; Matthews TJ; Borowitz MJ; Bigner SH
    Cancer; 1987 Apr; 59(7):1314-9. PubMed ID: 3028599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial Hodgkin's disease: a case report and review of the literature].
    Hofer HO; Nagel-Studer E; Nagel GA
    Onkologie; 1979 Jun; 2(3):113-8. PubMed ID: 230435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hodgkin's disease in a Swiss family].
    Fey MF; Joss RA; Pichler WJ; Laissue JA; Riedler GF; Schmid HJ; Brunner KW
    Schweiz Med Wochenschr; 1987 May; 117(20):761-6. PubMed ID: 3589632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease in siblings: a family study.
    Perlin E; Levine PH; McCoy J; Dean J; Herberman R
    Oncology; 1976; 33(3):116-8. PubMed ID: 189264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA in familial Hodgkin's disease.
    Conte R; Lauria F; Zucchelli P
    J Immunogenet; 1983 Jun; 10(3):251-5. PubMed ID: 6875280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA genotypes in familial Hodgkin's disease. Excess of HLA identical affected subs.
    Hors J; Steinberg G; Andrieu JM; Jacquillat C; Minev M; Messerschmitt J; Malinvaud G; Fumeron F; Dausset J; Bernard J
    Eur J Cancer (1965); 1980 Jun; 16(6):809-15. PubMed ID: 7408930
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
    Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
    Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Hodgkin's disease and the major histocompatibility complex.
    Bowers TK; Moldow CF; Bloomfield CD; Yunis EJ
    Vox Sang; 1977; 33(5):273-7. PubMed ID: 144365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC related genetic susceptibility to Hodgkin's disease.
    Kalidi I; Masset M; Gony J; Marcelli A; Jeannet M; Irlé C; Bauters F; Tchernia G; Turpin F; Gisselbrecht C
    Nouv Rev Fr Hematol (1978); 1989; 31(2):149-52. PubMed ID: 2771630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance.
    Chakravarti A; Halloran SL; Bale SJ; Tucker MA
    Genet Epidemiol; 1986; 3(6):407-15. PubMed ID: 3803911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA in familial Hodgkin's disease. Results and a new hypothesis;
    Marshall WH; Barnard JM; Buehler SK; Crumley J; Larsen B
    Int J Cancer; 1977 Apr; 19(4):450-5. PubMed ID: 844915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings.
    Kamper PM; Kjeldsen E; Clausen N; Bendix K; Hamilton-Dutoit S; d'Amore F
    Br J Haematol; 2005 Jun; 129(5):615-7. PubMed ID: 15916683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.